N-of-1 trials: Innovative methods to evaluate complementary and alternative medicines in pediatric cancer

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 4, 2006, Pages 263-266

  Sung, Lillian ^a,b   Feldman, Brian M ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DOXORUBICIN; PLACEBO; THEOPHYLLINE;

ALTERNATIVE MEDICINE; ATTENTION DEFICIT DISORDER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RELAPSE; CANCER RESEARCH; CHEMOTHERAPY INDUCED EMESIS; CHILDHOOD CANCER; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL MEDICINE; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG USE; DYSPNEA; ECONOMIC EVALUATION; EVALUATION; EXPERIMENTAL THERAPY; EXTERNAL BIAS; FATIGUE; FEASIBILITY STUDY; HUMAN; INTERNAL BIAS; JUVENILE RHEUMATOID ARTHRITIS; METHODOLOGY; MUCOSA INFLAMMATION; OUTCOME ASSESSMENT; PATIENT SELECTION; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS DESIGN; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; REVIEW; SAMPLE SIZE; SENSITIVITY ANALYSIS; STANDARD; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

CHILD; COMPLEMENTARY THERAPIES; CONTROLLED CLINICAL TRIALS; HUMANS; NEOPLASMS; PEDIATRICS; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 33646926763     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000212904.68899.1d     Document Type: Review

References (18)

1. Kratchwill TR, ed. Single Subject Research: Strategies for Evaluating Change. Orlando, Florida: Academic Press; 1978.
2. Mahon J, Laupacis A, Donner A, et al. Randomised study of n of 1 trials versus standard practice. BMJ. 1996;312:1069-1674.
3. Guyatt G, Sackett D, Adachi J, et al. A clinician's guide for conducting randomized trials in individual patients. CMAJ. 1988;139:497-503.
4. Anonymous. Randomised controlled trials in single patients. Drug Ther Bull. 1998;36:40.
5. Cook DJ. Randomized trials in single subjects: the N of 1 study. Psychopharmacol Bull. 1996;32:363-367.
6. Guyatt GH, Keller JL, Jaeschke R, et al. The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience. Ann Intern Med. 1990;112:293-299.
7. Zucker DR, Schmid CH, McIntosh MW, et al. Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment. J Clin Epidemiol. 1997;50:401-410.
8. Haines DR, Gaines SP. N of 1 randomised controlled trials of oral ketamine in patients with chronic pain. Pain. 1999;83:283-287.
9. Eide PK, Stubhaug A. Relief of glossopharyngeal neuralgia by ketamine-induced N-methyl-aspartate receptor blockade. Neurosurgery. 1997;41:505-508.
10. Estrada CA, Young MJ. Patient preferences for novel therapy: an N-of-1 trial of garlic in the treatment for hypertension. J Gen Intern Med. 1993;8:619-621.
11. Kent MA, Camfield CS, Camfield PR. Double-blind methylphenidate trials: practical, useful, and highly endorsed by families. Arch Pediatr Adolesc Med. 1999;153:1292-1296.
12. Jaeschke R, Adachi J, Guyatt G, et al. Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol. 1991;18:447-451.
13. Knowles SR, Uetrecht JP, Shear NH. Confirming false adverse reactions to drugs by performing individualized, randomized trials. Can J Clin Pharmacol. 2002;9:149-153.
14. Levitt AJ, Lippert GP. Psychogenic panic after zidovudine therapy: the therapeutic benefit of an N of 1 trial. CMAJ. 1990;142:341-342.
15. Karnon J, Qizilbash N. Economic evaluation alongside n-of-1 trials: getting closer to the margin. Health Econ. 2001;10:79-82.
16. Keller JL, Guyatt GH, Roberts RS, et al. An N of 1 service: applying the scientific method in clinical practice. Scand J Gastroenterol Suppl. 1988;147:22-29.
17. Mahon JL, Laupacis A, Hodder RV, et al. Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. Chest. 1999;115:38-48.
18. Johnston BC, Mills E. N-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation. J Altern Complement Med. 2004;10:979-984.